Treating Both Atrial Valves Improves Survival

Courtesy of Dr. Carlos Fava.

There a few treatment options for tricuspid valve disease. It is practically limited to diuretics and surgery, is associated to high mortality and, generally, mitral regurgitation. 

Estenosis aórtica moderada y disfunción ventricular ¿debería apurarse la indicación del recambio?

Developing the “edge-to-edge” strategy with MitraClip has been shown beneficial and, at present, there are studies that claim this technique could be greatly beneficial both tor the “forgotten” valve alone or in combination with the mitral valve. 

The study looked at 122 patients from the TriValve registry receiving combined transcatheter mitral plus tricuspid valve edge-to-edge repair (TMTVR) and 106 from the TRAMI registry receiving transcatheter mitral valve edge-to-edge repair (TMVR). They also presented severe tricuspid regurgitation. 

Mean age was 77; those receiving TMTVR were mostly women, had less severe left ventricular function deterioration <30% (18% vs. 39.4% p<0.001), end-diastole diameter (54 mm vs. 59 mm; p = 0.007), atrial fibrillation (68.7% vs. 55.7%; p= 0.029) and cardiac failure functional class IV (32.8% vs. 18.9%; p=0.013). In addition, glomerular filtration was lower.


Read also: Impella and Adverse Events.


EuroSCORE in the TRAMI group was 26.2% and in the TriValve group was 12.1%. Tricuspid annulus dilation was 47±8 mm in the TriValve group.

Procedural success in the mitral valve was similar, and was 81% in the tricuspid. In patients undergoing TMTVR, procedure duration prolonged 50 minutes. There were no differences in hospital evolution.


Read also: ACC Recommendations against the New Coronavirus.


At one-year follow-up, mortality was higher in TMVR patients (34% vs. 16.1% p=0.035), with no differences functional class improvement, which was significant. 

Conclusion

Joint treatment of both valves was associated to better survival vs. isolated mitral valve treatment in patients with severe mitral and tricuspid regurgitation. More randomized studies are necessary to confirm these results. 

Courtesy of Dr. Carlos Fava.

Original title: Combined Tricuspid and Mitral VersusIsolated Mitral Valve Repair for Severe Mitral and Tricuspid Regurgitation An Analysis From the TriValve and TRAMI Registries.

Reference: Michael Mehr, et al J Am Coll cardiol Intev 2020;13:543-50.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...